2. UroToday Home
  3. Video Lectures

Renal Cancer Videos

Whole-Genome Sequencing-Based MRD Detection Under Study in Resectable Renal Cell Carcinoma - Taigo Kato
RAMPART Study Investigates Quality of Life Impact of Durvalumab and Tremelimumab in RCC - Sophie Merrick
ZIRCON-X: CAIX PET Imaging and Its Role in Biopsy, Surgery, and Care Planning for Indeterminate Renal Masses - Brian Shuch
Phase II NESCIO Trial of Neoadjuvant Immunotherapy in Renal Cell Carcinoma - Femke Burgers
Neoadjuvant Pembrolizumab and Radiotherapy for Kidney Cancer - Muhammad Ali
Diagnostic Imaging and Treatment Options for Small Renal Masses - Fernando Pablo Secin
Identifying the Right Patient for [⁸⁹Zr]Zr-Girentuximab PET–CT Imaging in Clear Cell RCC - Vitaly Margulis
KIM-1 Biomarker Data from Adjuvant Immunotherapy Trials in Renal Cell Carcinoma - Wenxin Xu
Power and Replication Rates in Randomized Cancer Trials - Pavlos Msaouel
Study Examines CAIX-PET Imaging for Small Renal Mass Characterization - Timothy McClure
Validation Study of the GRANT Score for Papillary Renal Cell Carcinoma - Michele Maffezzoli
Advancing the Management of Indeterminate Renal Masses: The Emerging Role of Molecular Imaging - Alexander Kutikov
Combination HIF-2α/VEGF Dual Inhibition in Refractory Clear Cell RCC - Michael Serzan
ORACLE Study Explores Efficacy of Post-Combination Therapies in Non-Clear Cell RCC - Deepak Kilari
Pediatric-Inspired Trial Tests IO-TKI Combo for Translocation Renal Cell Carcinoma - James Geller
Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan
Adjuvant Pembrolizumab Shows Sustained Survival Benefit in Renal Cell Carcinoma at 5 Years - Naomi Balzer-Haas
STELLAR-002 Trial: Zanzalintinib Combo Explored in Clear Cell RCC - Jad Chahoud
AUA 2025 Highlights: Advances in Kidney Cancer - Elizabeth Koehne
Cost-Effectiveness of 89Zr-DFO-Girentuximab PET Scan for Small Renal Mass Diagnosis - Pratik Kanabur
Combination Lenvatinib-Tislelizumab for Fumarate Hydratase-Deficient Renal Cell Carcinoma - Wen Kong
Smoking Cessation as a Precision Cancer Care Intervention in Urologic Oncology - Richard Matulewicz
AI in Renal Mass Classification: Current Challenges and Future Potential - Nicholas Kavoussi
The Value and Limitations of Biopsies for Small Renal Masses - Phillip Pierorazio
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis - Beyond the Abstract
Outcomes with Novel Combinations in Non-Clear Cell RCC: ORACLE Study - Deepak Kilari
Microbiome Manipulation in the Treatment of Kidney Cancer - Monty Pal
Advancing Imaging Techniques for Indeterminate Renal Mass Diagnosis and Clinical Decision-Making - Sam Chang
Research Maps Renal Cancer Transcription Signatures - Pedro Barata
Innovative Therapies in GU Cancers: Promising Targets in Urothelial and Kidney Cancer - Jonathan Rosenberg
Oligometastatic vs Oligoprogressive RCC Treatment Strategies - Chad Tang
Highlights in Non-Prostate GU Oncology from ESMO 2024 - Ignacio Duran
Glycoproteomics in Kidney Cancer: CheckMate 9ER Biomarker Analysis - David Braun
CaboPoint Trial: Cabozantinib in Second-Line RCC Treatment - Laurence Albiges
Fecal Microbiota Transplant Boosts Immunotherapy in Metastatic Renal Cell Carcinoma in TACITO-II Trial - Chiara Ciccarese
HIF-2 Alpha Inhibitor NKT2152 Shows Impact in Renal Cell Carcinoma - Eric Jonasch
GPT-4 in Urology: Revolutionizing Renal Surgery Data Extraction - Jessica Hsueh & Mark Ball
Advancing Radiopharmaceuticals: Targeting Strategies and Isotope Selection in Cancer Therapy - John Babich
Advancing RCC Treatment: PROSPER Trial Analysis and Future Directions - Naomi Haas
Understanding KEYNOTE-564: Pembrolizumab’s Role and Post-Adjuvant Therapy for RCC Patients - Karl Semaan & Talal El Zarif
Functional Renal Imaging and Advances in Kidney Cancer Detection - Shankar Siva
Update on Biomarkers in Renal Cell Carcinoma - David Braun
KEYNOTE-564 Shows Overall Survival Benefit in Kidney Cancer with Pembrolizumab - Toni Choueiri
Socioeconomic Disparities Drive Alarming Racial Gaps in Kidney Cancer Patient Survival Rates - Nirmish Singla
Addressing the Gaps in Quality of Life: A New Measure for Renal Cell Carcinoma Patients - Cristiane Bergerot
Enhancing Patient-Centered Communication in Small Renal Mass Management - Kathryn Hacker Gessner
Advancing Treatment for Non-Clear Renal Cell Carcinoma: Insights and Future Directions (PAPMET & PAPMET 2) - Benjamin Maughan
Brain Metastases From Renal Cell Carcinoma Treated With First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium - Kosuke Takemura
Results from the Phase 3 Study of 89Zr-DFO-Girentuximab for PET/CT Imaging of Clear Cell Renal Cell Carcinoma (ZIRCON) - Brian Shuch
Fueling Wellness with Flavor for Cancer Patients: The Wellness Principles - Gary Deng
The Role of Everolimus in the Adjuvant Setting for Patients with Renal Cell Carcinoma: EVEREST (SWOG S0931) - Christopher Ryan
The ORACLE Study: The Efficacy of Combination Systemic Therapies in Patients with Non-Clear Cell Renal Cell Carcinoma - Deepak Kilari
Atezolizumab as Adjuvant Therapy After Resection for Patients with Renal Cell Carcinoma with Increased Risk of Recurrence: IMmotion010 Trial, Journal Club - Zachary Klaassen
Results of a Phase II Randomized Double Blind Trial of PF-04518600, OX40 Antibody, in Combination with Axitinib - Sarmad Sadeghi
Pembrolizumab in Combination with Lenvatinib as First-Line Treatment for Non Clear Cell Renal Cell Carcinoma (nccRCC), KEYNOTE-B61 - Laurence Albiges
Why Not Biopsy? Challenging the Status Quo in Renal Mass Management - Jaime Landman
How Office-Based Renal Biopsies Could Upend Current Urological Guidelines - Jaime Landman
Superfluous Hospital Expenditure Associated with Unnecessary Renal Cyst Surveillance - Lee Ponsky & Laura Bukavina
CT Guided Percutaneous Renal Mass Cryoablation - Daniel Watson
Supine PCNL (Ambulatory): Who? What? When? Why? How? - James F. Borin
Outpatient Renal Procedures - Ashley Baker
The Role of Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma - Neeraj Agarwal, MD
Advances of Systemic Treatments in Renal Cell Carcinoma - Jens Bedke
Office-based, Ultrasound-Guided Renal Mass Biopsy: Technique and Results - Jaime Landman
Patient Advocacy and Resources in Kidney Cancer - Dena Battle
Treatment Strategies in Kidney Cancer and the Results of CARMENA - Toni Choueiri